Lumida
/ADVM
⌘K
Adverum Biotechnologies Inc

Adverum Biotechnologies Inc

ADVM
$4.36USD+2.35%+0.10 today

MARKET CAP

96.3M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$2
$6
STATEMENT·Income statement
USD · GAAP
METRICFY 2019FY 2020FY 2021FY 2023FY 2024TREND
Sales, Adj.$250,000$0$7.5M$3.6M$1.0M
YoY %-84.5%-100.0%-72.2%
P / Sales
EV / Sales
Gross Profit, Adj.$250,000$0$7.5M$3.6M$1.0M
YoY %-84.5%-100.0%-72.2%
Margin %100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-67.0M$-113.8M$-141.5M$-123.3M$-135.5M
YoY %+6.1%-69.9%-24.3%+15.9%-9.9%
Margin %-26788.8%-1886.4%-3424.9%-13550.6%
EV / EBITDA
EBIT$-68.5M$-118.0M$-146.1M$-128.9M$-139.2M
YoY %+12.2%-72.1%-23.9%+17.9%-7.9%
Margin %-27418.0%-1948.3%-3581.7%-13915.9%
EV / EBIT
Net Income$-64.5M$-117.5M$-145.5M$-122.1M$-130.9M
YoY %+11.2%-82.2%-23.9%+21.0%-7.2%
Net Margin-25794.4%-1940.5%-3392.1%-13092.7%
EPS (GAAP)-$10.10-$13.80-$14.80-$12.11-$6.62
YoY %+14.4%-36.6%-7.2%+22.4%+45.3%